Regeneron Pharmaceuticals (REGN) Tax Rate Growth (3y) (2014 - 2026)

Regeneron Pharmaceuticals (REGN) Tax Rate Growth (3y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,011.97 Bn 67,011.68 Bn -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 471.88 Bn 467.08 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.20 Bn 114.96 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.93 Bn 61.17 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.85 Bn 50.67 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn
10 Revolution Medicines 37.26 Bn 37.26 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 783.00
Dec 31, 2025 944.00
Sep 30, 2025 434.00
Jun 30, 2025 -317.00
Mar 31, 2025 239.00
Dec 31, 2024 -674.00
Sep 30, 2024 6.00
Jun 30, 2024 -540.00
Mar 31, 2024 -1,404.00
Dec 31, 2023 -720.00
Sep 30, 2023 -637.00
Jun 30, 2023 822.00
Mar 31, 2023 -190.00
Dec 31, 2022 -136.00
Sep 30, 2022 -1.00
Jun 30, 2022 -253.00
Mar 31, 2022 -731.00
Dec 31, 2021 3,229.00
Sep 30, 2021 367.00
Jun 30, 2021 147.00